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1.1 Cancer-related inflammation 
Worldwide occurrence of autoimmune diseases and cancer is 
increased, this is particularly clear in more developed countries [1]. 
Several environmental factors, including pollution and increased 
average age, may play a role and partially explain this observation, but 
the concurrence of inflammation and cancer seems to be connected and 
not independent. Similarly, 
but from the opposite 
direction, the introduction of 
non-steroidal anti-
inflammatory drugs to 
protect for chronic 
inflammatory syndromes 
was able to protect patients 
from the increased risks of 
cancer development [2]. Epidemiological studies demonstrated that 
chronic inflammation predisposes to different forms of cancer, thus 
cancer-related inflammation, was recently included as the seventh 
hallmark of cancer [3].  
Before the introduction of effective therapeutic options, 
inflammatory bowel diseases (IBDs) were associated with increased risk 
of developing colorectal cancer (CRC). IBDs are chronic inflammation of 




the gut that include Crohn Disease (CD) and Ulcerative Colitis (UC). 
IBDs are multifactorial disorders characterized by, abdominal pain, 
diarrhea and rectal bleeding [4].  
In patients with long-established IBD, the risk of developing colon 
cancer is increased, thus CRC was the perfect target to study the axis 
between chronic inflammation and cancer. 
CRC was first recognized as a complication of ulcerative colitis 
(UC) by Crohn and Rosenberg in 1925. Although CRC in UC patients 
only accounts for 1% of all cases of CRC seen in the general population, 
it accounts for one sixth of all deaths in UC patients. For this reason, it 
deserves a great attention. Since 1925, numerous epidemiological 
studies have confirmed an increased risk of CRC for UC patients in the 
first decade after an UC diagnosis [4]. More recent studies have reported 
that this risk at later stages of UC has decreased markedly over time and 
no longer exceeds that of the general population. Although the risk in 
adults continues to be a matter of debate, the general consensus from all 
studies agrees with the view that CRC risk is highest in patients who are 
diagnosed with UC during childhood, adolescence or young adulthood, 
especially in male patients. The reduced risk of CRC incidence in older 
UC patients over time reflects the results of improvements in the therapy 
of IBD patients and the introduction of routine endoscopic screening [5].  
Corticosteroids and especially, 5-ASA and thiopurines are used 
as chemopreventive agents due to their ability to inhibit, delay or reverse 
CRC in UC. Recently, biologic agents have been introduced for the 
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induction and the maintenance of therapy in IBD patients. In Europe, 
the approved agent is infliximab, a monoclonal antibody that blocks 
tumor necrosis factor α (TNFα), one of the most important molecules 
involved in the pathogenesis of IBD.  
However, conflicting reports exist concerning the relationship between 
infliximab and an increased risk of CRC and other forms of cancer in IBD 
patients receiving such therapy. While infliximab treatment has been 
associated with the development of carcinoid tumor, signet ring cell 
carcinoma of the bowel, breast cancer, lung cancer, and colorectal cancer, 
however, in other cases there was no significantly increased risk of 
cancer by TNFα antagonist exposure [6]. It is tempting to speculate that, 
due to the recent introduction of biological agents into the clinical 
practice, long-term observational studies of these treatment sequelae are 
needed. Furthermore, these divergent data are reported to be due to 
perhaps the intrinsic dual nature of the immunomodulatory drugs that 
both induce a decreased immunosurveillance, thereby providing 
advantages for oncogenic viruses, and exert a direct oncogenic effect for 
certain immunosuppressive drugs. These effects are not limited to the 
intestinal epithelium; in fact, cases of extra-intestinal neoplasia, such as 
lymphoproliferative disorders, skin and uterine cervical cancer have 
been reported in IBD patients under immunosuppressive treatment. 
Thus, immunosuppression and inflammation are the two main drivers 
of IBD-related carcinogenesis. The challenge is that these two 
mechanisms may be interlinked, particularly in the intestinal tissues.  
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The dual nature of TNFα activity is responsible for its paradoxical 
anti- and protumor activity depending on cell type, environment, dose, 
and other factors. On one hand, TNFα exerts its anti-tumoral potential 
by its interaction with death domain containing proteins and caspases 
that induce apoptosis. On the other hand, TNFα has a pro-tumoral 
activity resulting from the activation of NF-κB and mitogen-activated 
protein kinase pathways, which are in turn associated with 
inflammation and carcinogenesis [7].  
 
1.2 Inflammatory bowel diseases  
Inflammatory bowel diseases (IBD) include Crohn’s Disease (CD) 
and Ulcerative Colitis (UC), which are both chronic relapsing 




regulated to a 





bacteria and food derived antigens. However, breaches of mucosal 
immune tolerance can occur due to both environmental and genetic 




factors resulting in perturbed intestinal homeostasis. Several different 
events can trigger inflammatory responses that may result in chronic 
inflammation and pathological changes associated with IBD. A common 
ground for this multifactorial disorder is an increased production of 
diverse panel of cytokines, [9] some of which are pro-inflammatory and 
hence targets for therapeutic blockade.  







dramatically changed the medical approach to IBD. Similar to CD, a 
subgroup of UC patients also exhibit increased TNFα levels in the colon. 
In fact, Braegger et al. reported the presence of TNFα in stool samples in 
such UC patients [10]. Animal models have significantly contributed to 
the elucidation of the pathological mechanisms of IBD and to the 





Figure 3. Perturbed intestinal homeostasis and cytokine production in IBD patients [9]. 
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1.3 Animal models of CRC 
To dissect the intricate relationship 
between inflammation and increased 
cancer risks we decided to take 
advantage of the well consolidated 
murine models of genetic predisposition 
leading to CRC (APCmin mice) and a low 
grade, spontaneous and progressive UC 
model (Winnie). We created a new murine model of colitis-associated 
cancer, the Winnie-APCMin model [12].  
The APCmin murine model is among the most frequently used model to 
study colorectal cancer (CRC), even if conventional protocols require the 
administration of dextran sodium sulfate (DSS) as inflammatory insult 
to develop CRC in a relatively short time. DSS specifically acts on the 
intestinal epithelium 
integrity to induce an 
acute inflammation 
characterized by 
multiple events that 
poorly represent the 
cascade of events that 
characterize the human 
ulcerative colitis [13-
15].  
Figure 4. H&E stain for histopathology of 
a murine colonic tumor tumor.  




To overcome this bias and create a reliable model of inflammatory 
induced CRC, we crossed APCmin with Winnie mice. Winnie colitis is due 
to a missense mutation in the Muc2 mucin gene resulting in spontaneous 
distal colitis developing as early as 5 weeks of age [16]. This intestinal 
epithelial defect conferring endoplasmic reticulum (ER) stress results in 
inflammation involving both innate and adaptive immunity. In the 
Winnie mouse the colonic pathology is predominantly mediated by the 
dysregulation of numerous cytokines, including elevated TNFα similar 
to human UC where the intestinal inflammation is most severe in the 
distal colon and the disease severity increases with age. 
The risk of neoplastic progression in IBD is multi-factorial.  This 
heterogeneity may at least in part be due to differences in genetic 
susceptibility, which may act in combination with various 
environmental factors including diet and intestinal microbial 
community [17]. In particular, the intestinal microbiota has recently 
acquired a great interest in the context of inflammation and 
carcinogenesis [18]. Murine models allow investigation of the intestinal 
microbiota and CRC-associated dysbiosis.  
For this reason, in parallel with the creation of a Winnie-APCmin colony, 
we investigated the possibility to use nutritional strategies to reduce the 
intestinal inflammation and prevent the associated intestinal dysbiosis. 
As dysbiosis has recently been suggested as the cause of disease 
recurrence for patient that achieved UC clinical remission, nutritional 
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strategies may prevent dysbiosis and, consequently, remove one of the 
inflammatory insult required for CRC development. 
1.4 Anti-inflammatory effects of polyphenols 
 
A major field of investigation of our laboratory is characterization of the 
anti-inflammatory properties of plant-derived polyphenols.  Dietary 
polyphenols are associated with a wide range of health benefits, 
protecting against chronic diseases and promoting healthy aging. 
Dietary polyphenols offer a complementary approach to the treatment 
of inflammatory bowel diseases (IBD), a group of common chronic 
intestinal inflammation syndromes for which there is no cure. Several 
studies have described the beneficial effects of plant-derived 
polyphenols as natural ligands that are able to reduce inflammation, 
with some inhibiting production of TNFα from cell lines of different 




origins in both in vitro and in vivo models [19, 20]. In our laboratory we 
previously compared numerous polyphenols and identified quercetin as 
one of the most potent suppressor of the inflammatory response [21]. 
Quercetin, similarly to many other phytochemicals, is a hydrophobic 
compound characterized by low solubility in water and consequent low 
bioavailability. These major limitations can be bypassed by developing 
efficient delivery systems that have the ability to protect, as well as 
release, polyphenols at the appropriate site of action. A wide variety of 
new delivery systems has been proposed, including liposomes, 
nanoparticles, and nanoemulsions [22]. Among these, plant oil bodies 
(OBs) represent a convenient and feasible option to achieve the 
aforementioned goals. OBs are lipid storage vesicles that are naturally 
found in plant seeds. Isolated OBs are remarkably stable due to the steric 
hindrance and electro-negative repulsion provided by surface proteins 
of the organelles [23, 24]. Reconstituted oil bodies (ROBs), as well as 
native OBs, have been previously reported as useful vehicles for the 
stabilization of curcumin and previously used by our research group to 
demonstrate the ability of polyphenol administration to suppress 
dendritic cells inflammatory pathway [21].  
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Another strategy recently-developed strategy to administrate hi-doses 
of stable polyphenols was developed by the research group of Prof. 
Cathie Martin [25]. In 
2008 they created a 




comparable to the 
anthocyanin levels 
found in blackberries and blueberries. Possibly due to the polyphenol 
anti-inflammatory abilities and the previously unknown effect to the 
intestinal microbial communities, the administration of these tomato 
fruit to cancer-susceptible Trp53−/− mice resulted in a significant 
extension of life span [25].  
We recently obtained new lines of dried tomatoes fruit enriched in 
polyphenols to evaluate possibility to use nutritional regimes enriched 
in polyphenols to suppress the chronic intestinal inflammation and 
protect from intestinal dysbiosis.  
 
  





2.1 Creation of a murine model of inflammatory induced CRC 
The development of murine models to study CRC development and 
progression has been crucial to better understand the disease and to 
develop new therapies. The most frequently used murine models of 
tumor development combine the administration of the carcinogen agent 
azoxymethane or the genetic predisposition APCmin with various agents 
promoting colonic injury such as DSS, oxazolone or enterotoxic bacteria 
Bacteroides fragilis [13, 26-28]. The aim of the study was to create a new 
murine line of spontaneous inflammatory-induced colorectal cancer 
combining the genetic predisposition APCmin with the mutation in the 
Muc2 gene that results in ER stress and spontaneous mild and 
progressive UC. 
In particular, we aim to: 
 Create and establish the Winnie-APCmin colony.  
 Characterize the development of neoplastic lesion in the intestine of 
this new model. 
 Characterize the intestinal molecular fingerprint of the new murine 
lines. 
 Characterize the intestinal microbiota of the new murine lines. 
 
2.2 Nutritional strategies to suppress intestinal inflammation and 
dysbiosis 
Together with numerous other research group, we already reported the 
anti-inflammatory potential of numerous natural bio-active compounds 
as potential candidate for prevention and treatment of the intestinal 
inflammatory response. [21, 29, 30] Despite evidences for the biological 
effects of these phytonutrients being reported, knowledge of the 
underlying molecular mechanisms activated upon polyphenols 
treatment remain poorly understood. A second parallel aim of the study 
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was to explore the possibility to prevent intestinal inflammation using 
nutritional derived bioactive compounds. To achieve this goal we 
studied the effects of quercetin administration to in-vitro cultured 
dendritic cells that are the most powerful antigen presenting cells. 
Furthermore we tested the effects of polyphenol enriched diet to the 
relative abundance of intestinal microbial species. 
In particular, we aim to: 
 Identify quercetin induced molecular mediators suppressing the 
inflammatory response. 
 Characterize the mechanism of the quercetin induced inflammatory 
suppression. 
 Evaluate the effects of nutritional intervention in the murine model 




3.01 Mice  
The new murine transgenic line Winnie-APCMin was created by breeding 
Winnie mice, a murine line established from Dr. Eri’s group at the 
University of Tasmania, with APCMin mice murine line on a C57BL/6J 
background. WT, APCMin and secretory leukocyte protease inhibitor 
(SLPI) knockout mice murine lines were purchased from Jackson 
Laboratories (C57BL/6J, Stock No. 000664, C57BL/6J-ApcMin/J, Stock 
No. 002020, B6; 129-Slpitm1Smw/J,  Stock No: 010926 respectively) (Bar 
Harbor, ME, USA). All animal experiments were carried out in 
accordance with EU Directive n.63/2010 enforced by Italian D.L. 
n.26/2014, and approved by the Committee on the Ethics of Animal 
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Experiments of Ministero della Salute – Direzione Generale Sanità 
Animale (768/2015-PR 27/07/2015) and the official RBM veterinarian. 
Animals were sacrificed if found in severe clinical condition in order to 
avoid undue suffering. Winnie-APCMin mice and their parental lines 
were sacrificed at 5 weeks and colon was explanted to evaluate the 
clinical severity of colitis. C57BL/6 and Winnie mice were treated with 
different diet and sacrificed after two weeks of treatment. For the latter, 
mice weight, pellet consumption and drinking water were monitored on 
a daily basis. Each group of mice received a different diet. Freeze-dried 
tomato was supplemented by addition to a standard rodent diet (4RF18) 
at 1% (tomato based-diets). Groups of mice were fed with the different 
tomato supplemented diets for two weeks. Body weight, stool 
consistency and rectal bleeding were recorded. Mice were sacrificed at 
day 14, and colon and mesenteric lymph node (MLN) tissues were 
explanted to evaluate the clinical severity of colitis. Colon length and 
weight were measured as indicators of colonic inflammation. The 
colon/body weight indices were calculated as the ratio of the colon wet 
weight and the total body weight (BW), and as the ratio of the colon 
length and the total BW of each mouse. Genotyping was performed by 
PCR (APCMin) and qPCR (Winnie) from 5mm tail tissue obtained from 
4-week old mice, DNA was extracted using DNeasy® kit purchased by 
QIAGEN and following manufacturer’s instructions. For APCMin we 
followed the official PCR protocol described by the Jackson Laboratory 
(https://www2.jax.org/protocolsdb/f?p=116:2:0::NO:2:P2_MASTER_PR
OTOCOL_ID,P2_JRS_CODE:15431,002020); for Winnie mice we 
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performed a single nucleotide polymorphisms (SNP) genotyping 
analysis using a custom TaqMan® Assay (AHCSX8U) to discriminate 
for the presence of a point mutation on the Mucin 2 gene by a real-time 
PCR reaction.  
 
3.02  Histology 
Tissue sections from large intestine were fixed in 10% buffered formalin, 
dehydrated and paraffin embedded. Based on the major intestinal axis, 
the samples had a length variable between 0.5 cm and 1.5 cm and span 
of all the colonic wall. We evaluated a mucosal area between 7.5 mm2 
and 22.5 mm2 wide with a mean measure of 15 mm2. 3µm thick-sections 
from proximal, medial and distal colon were stained with H&E 
following standard protocols. Colonic tissue sections were evaluated for 
inflammatory features and neoplasia. Periodic acid–Schiff (PAS) staining 
on distal colon sections was performed to identify mucins. Observations 
and imaging were performed with Nikon Eclipse Ti2.  
 
3.03  RNA extraction and qPCR analysis 
Total RNA was isolated from the medial part of the large intestine or 
bone marrow derived dendritic cells (BMDCs). The RNA was extracted 
using TRIzol® (Thermo Fisher Scientific, MA, USA) according to 
manufacturer’s instructions and reverse transcribed with I Script 
Reverse Transcription Supermix (BioRad Laboratories, CA, USA). 500ng 
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of total RNA was reverse transcribed with the High Capacity cDNA 
Reverse Transcription kit (Thermo Fisher Scientific, MA, USA) by using 
random primers for cDNA synthesis. Gene expression of Il1β, Ifnγ, Il12, 
Il10, Il4, TNFα, Slpi, Hmox1 and Gapdh was performed with TaqMan 
Gene Expression Assays (Thermo Fisher Scientific MA, USA) murine 
probes: Mm00434228_m1, Mm01168134_m1, Mm01288989_m1, 
Mm00439614_m1, Mm00445259_m1, Mm00443258_m1, 
Mm00441530_g1, Mm01254822_m1, Mm99999915_g1, respectively. 
Tier-based gene expression analysis was performed by using Colonic 
neoplasms Tier 1 M96 (Cat.#100-36551, Biorad, CA, USA). Real-time 
PCR was performed on CFX96 System (Biorad, Hercules, CA, USA). The 
expression of all target genes was calculated relative to Gapdh 
expression using ΔΔCt method.  
 
3.04 Bacterial microbiome metagenomics 
Total genomic bacterial DNA was isolated from frozen stool samples of 
4- , 8- and 16-week old WT and Winnie mice (4 samples/genotype for 
each timing) using the QIAamp® Fast DNA Stool Mini Kit (QIAGEN, 
Hilden, Germany), according to manufacturer’s instructions.  
16S metagenetics were carried out at Genomix4life (spin-off of the 
University of Salerno, Italy) by using the Illumina MiSeq platform. The 
V3-V4 region of the 16S rRNA gene for analysis of diversity inside the 
domains of Bacteria was amplified.18 PCR and sequencing analyses 
were carried out according to the protocol of Genomix4life. Quality 
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control (QC) and taxonomic assignments were undertaken according to 
the QIIME and the Ribosomal Database Project Bayesian classifier in 
combination with a set of custom designed informatics pipelines 
implemented by Genomix4life for analyses of microbial communities. 
Taxonomic attribution was carried out using the BLAST search in the 
NCBI 16S ribosomal RNA sequences database.19 The percentage of each 
bacterial OTU was analysed individually for each sample, providing 
relative abundance information among the samples based on the relative 
numbers of reads within each.20  Alpha-diversity indexes were 
evaluated using the number of OTUs, Chao1 species richness and the 
Shannon index. Alpha diversity was calculated using Qiime.21-22  
 
3.05 Generation and culture of murine DCs 
DCs were harvested from murine bone marrow (BM). Briefly, BMs from 
the tibiae and femurs of 6- to 8-week-old male C57BL/6 and Slpi-KO 
mice were flushed with 0.5mM EDTA (Thermo Fisher Scientific, MA, 
USA), and depleted of red blood cells with ACK lysing buffer (Thermo 
Fisher Scientific, MA, USA). BMDCs were plated in a 10 ml dish (1x106 
cells/mL) in RPMI 1640 (Thermo Fisher Scientific, MA, USA) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS, 
Thermo Fisher Scientific, MA, USA), 100 U/mL penicillin (Thermo 
Fisher Scientific, MA, USA), 100 mg/mL streptomycin (Thermo Fisher 
Scientific, MA, USA), 25 µg/mL rmGM-CSF (Miltenyi Biotec, Bergisch 
Gladbach, GER), and 25 µg/mL rmIL-4 (Miltenyi Biotec, Bergisch 
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Gladbach, GER) at 37°C in a humidified 5% CO2 atmosphere. On day 5 
BMDCs were harvested, restimulated with new growth factors and 
plated at 1x106 cells/mL on 24-well culture plate. BMDCs were treated 
with 25µM of quercetin from Sigma (Sigma-Aldrich, St Louis, MO, 
USA) on day 5 and day 7. On day 8 BMDCs were stimulated with 1 
µg/mL of LPS (L6143, Sigma-Aldrich, St Louis, MO, USA) for 24 hours. 
To evaluate the iron-induced inflammatory cytokine secretion, 
differentiating cells (at day 7) were treated with quercetin (Sigma-
Aldrich, St Louis, MO, USA) or OH-piridone used as control chelator. 
Immediately after, FeCl3 (Sigma-Aldrich, St Louis, MO, USA) and 
Ascorbic Acid for 24 hours were additioned in the culture media. On 
day 8 BMDCs were stimulated with 1 µg/mL of LPS (Sigma-Aldrich, St 
Louis, MO, USA) for 24 hours. For mRNA expression differentiating 
cells were treated with quercetin on day 5 and day 7. On day 8 BMDCs 
were stimulated with 1 µg/mL of LPS ( Sigma-Aldrich, St Louis, MO, 
USA) for 6 hours. 
 
3.06 Purification of OBs 
OBs were extracted from almond seeds.  OB purification was carried out 
by a two-layer flotation procedure as previously reported [31], and a 
further purification step was performed consisting of two sequential 
washings with 2.0 M NaCl.  OBs were finally resuspended in 150 mM 




3.07 Quercetin and piperine encapsulation into ROBs 
Quercetin and piperine were encapsulated into the ROBs using the 
above reported protocol [31] with few modifications.  Natural OBs were 
resuspended in 150 mM TRIS-HCl pH 7.5, containing 0.5 M sucrose, 1 
mM EDTA, 10 mM KCl, 1 mM MgCl2, 5 mM ascorbic acid (buffer A) and 
twice extracted with chloroform : methanol (2:1), in order to separate PLs 
and proteins from TAGs.  After centrifugation at 1000 g for 5 minutes, 
the upper phase was extracted with five volumes of diethyl ether 
anhydrous (to recover TAGs).  All the recovered fractions were dried by 
a rotavapor. ROB reconstitution mixture consisted of the whole 
chloroform-methanol phase (PLs) with a quercetin (or piperine)/TAGs 
ratio of 1/250 starting from 2 mg of each phytochemical.  The final 
volume was adjusted to 3 ml by the addition of buffer A.  Samples were 
sonicated by a Brandson digital Sonifier 250-D at an amplitude of 40% 
and a cycle of 30 seconds pulse on and 30 seconds off for three times.  
After sonication, samples were centrifuged at 2000 g for 10 minutes and 
ROBs containing quercetin or piperine were recovered from the top of 
the centrifuge-tubes. HPLC analysis was carried out extracting the 
encapsulated phytochemicals using 2 volumes of ultrapure water, 2 
volumes of methyl-butyl-ether, and 1 volume of methanol.  After 
centrifugation at 1000 g for 5 minutes, the methyl-butyl-ether phase was 
recovered, dried (rotavapor), and resuspended into 50% ethanol.  
Quercetin was quantified by reverse phase-HPLC using the method 
described above [32] onto a 1100 Agilent work chromatographic station 
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equipped with a photodiodes array UV-Vis detection system.  The 
elution profile was monitored at 370 nm.  Quercetin, purchased from 
Sigma-Aldrich, was used as standard. 
 
3.08 Microarray gene expression analysis of ROBS-QP-treated DCs 
BMDCs were isolated and cultured as described. On day 5 and day 7 
BMDCs were treated with ROBs-QP (25 µM). LPS was administered [1 
µg/mL] at day 8 and 6 h later BMDCs were harvested. Total RNA was 
isolated with QIAzol (Qiagen, Hilden, GER) and treated with DNAase1 
(Ambion). RNA integrity was assessed using the BioRad Experion 
System (BioRad Laboratories). RNA was amplified using the Illumina 
TotalPrep RNA Amplification kit (Ambion). The quantity and quality of 
biotin-UTP incorporated 
cRNA was also assessed using the BioRad Experion System as 
previously described. Whole-genome gene expression experiments were 
conducted using MouseRef-8 v2.0 Expression Bead-Chips (direct 
hybridization assay) on the Illumina iScan microarray platform 
(Illumina). Data were processed through specific algorithms of filtration 
and cleaning of the signal of the Illumina Genome Studio Software (Cut 
off: detection p-value < 0.005; AVG signal<100). Final output consisted 
of fluorescence intensity of each probe (AVG signal), representing the 
expression levels of each gene after quantile normalization. All the genes 
differentially expressed (“Differential Expression Analysis” with the 
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“Illuminacustom error model” and with false Discovery Rate to adjust 
the p-value) between groups were analyzed using the Core Analysis 
function of Ingenuity Pathway Analysis (Ingenuity System Inc., 
Redwood, CA, USA) to identify biological functions, pathways, and 
networks. 
 
3.09 Small interfering RNA (siRNA) 
siRNA transfection was performed in BMDCs culture from WT mice 
obtained as described before. Cells were cultured at 1x106 in a 12-well 
plate and the transfection was carried out at day 4 using Lipofectamine 
3000 (Thermo Fisher Scientific, MA, USA) in accordance with 
manufacturer’s procedure. siRNA for Slpi were purchased from Thermo 
Fisher Scientific (s202008) and used at a final concentration of 40 pmol. 
In transfection experiments a mock-transfection control was performed 
by putting cells through the transfection procedure without adding 
siRNA. The Silencer Select Negative Control siRNA (4390843, Thermo 
Fisher Scientific, MA, USA) and Silencer® Select GAPDH Positive 
Control siRNA (4390849, Thermo Fisher Scientific, MA, USA) were used 
as negative control and positive control, respectively, for the setup of 
siRNA transfection. Each transfection experiment was done in triplicate. 
On day 5, cells were treated with 25 µM of quercetin and the day later 
cells were stimulated with 1 µg/ml of LPS. After 24 hours, cells were 
24 
 
lysed with TRIzol® (Thermo Fisher Scientific, MA, USA) and used for 
total RNA extraction. 
 
3.10 ELISA 
Cell culture supernatants were analyzed for IL-6, IL-12p70 and TNFα 
release in triplicate, using an ELISA kit (R&D Systems, Minneapolis, 
MN, USA) following manufacturer’ instructions. 
 
3.11 Iron staining 
BMDCs, were plated for 24h into Glass Bottom Cell Culture Dishes 
(MatTek corporation P35G-1.5-14.C), and treated with and without 
quercetin and FeCl3 (day 7). Following BMDCs cultures were exposed 
to 1 µg/mL of LPS and stained with The Iron Stain Kit (GENTAUR 
Molecular Products; IRN-2 Belgium) for the determination ferric iron 
deposits in tissue samples. This product is based on the Prussian Blue 
reaction in which ionic iron reacts with acid ferrocyanide producing a 
blue color. BMDCs were fixed in 1% paraformaldehyde and then stained 
following manufacturer instructions. 
 
3.12 Western blotting  
The amount of Hmox1, after stimulation of quercetin, was determined 
by Western blot analysis. Total protein extract were prepared with lysis 
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buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 8), 1% NonidetP-
40, 0.1% sodium deoxycholate, 0.1% SDS, plus proteinase inhibitors. The 
protein concentration was determined by the Bradford assay (BioRad, 
CA, USA). 30 µg of each protein lysate was separated on a 10% SDS-
PAGE and transferred to polyvinyldene difluoride (PVDF) membrane 
(Millipore, MA, USA). The membranes were incubated in 5% non-fat 
milk powder diluted in PBS containing 0.1% Tween-20 (T-PBS) for 2h at 
room temperature (RT) and probed with a rabbit polyclonal anti–Hmox1 
antibody (PA5-27338 ThermoFischer scientific MA, USA) in blocking 
buffer overnight at 4°C at a final dilution of 1:1000. Finally, membranes 
were incubated with secondary antibody of horseradish peroxidase 
conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, CA, USA) at 
a final dilution of 1:5000. Immunocomplexes were detected with the ECL 
method (GE Healthcare, Little Chalfont, UK). The same membranes 
were stripped and re-probed with anti-α-tubulin monoclonal antibody 
(Santa Cruz Biotechnology) at a final dilution of 1:2000. Images of 
Western-blots were acquired and quantified using a ChemiDoc MP 
(BioRad, CA, USA) apparatus. Ratio between intensities of Hmox1 and 
α-tubulin bands was used to normalize Hmox1 in each sample. 
 
3.13 Tomato-enriched diet administration.  
The Bronze tomato line (E8:MYB12, E8:Del/Ros, 35S:StSy) was 
developed as previously described [34]. Freeze-dried tomato was 
supplemented by addition to a standard rodent diet (4RF18) at 1% 
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(tomato based-diets). Mice, pellet consumption and drinking water were 
monitored on a daily basis. 
Sex- and weight-matched mice were divided in 5 groups (5 WT mice 
each).  Each group of mice received a different diet. Groups of mice were 
fed with the different tomato supplemented diets for two weeks. Stools 
were collected and stored at -80°C. 
For the intervention experimental setup, sex- and weight-matched mice 
were divided into four groups (four mice each). Groups of mice (WT and 
Winnie) were fed with the different tomato supplemented diets for two 
weeks. Mice were sacrificed at day 14, and colon and mesenteric lymph 
node (MLN) tissues were explanted to evaluate the clinical severity of 
colitis. Colon length was measured as an indicator of colonic 
inflammation. The colon/body weight indices were calculated as the 
ratio of the colon wet weight and the total body weight (BW), and as the 
ratio of the colon length and the total BW of each mouse. Body weight, 
occult and rectal bleeding and stool consistency were monitored daily. 
Disease activity index (DAI) was determined by scoring changes in body 
weight, occult blood and gross bleeding. 
 
3.14 Cytofluorimetric Analysis 
FoxP3 staining: Mesenteric lymph nodes (MLNs) were isolated from 
mice fed with tomato (Control or Bronze)-enriched food. MLNs were 
passed through a 30 µm cell strainer (Miltenyi Biotec, Bergisch 
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Gladbach, Germany) to obtain a single cell suspension and then washed 
with DPBS (Gibco, Waltham, MA, USA) + 0.5% bovine serum albumin 
(BSA, Sigma-Aldrich, St. Louis, MO, USA). Single cell suspensions were 
stained with CD4-FITC and CD25-PE (Miltenyi Biotec, Bergisch 
Gladbach, Germany). Cells were then permeabilized with Foxp3 
Fixation/Permeabilization Kit (eBioscience, San Diego, CA, USA) and 
subsequently washed with PERM Buffer (eBioscience, San Diego, CA, 
USA). Finally, cells were stained with Foxp3-APC (Miltenyi Biotec, 
Bergisch Gladbach, Germany), according to the manufacturer’s 
instructions. Flow Cytometer acquisition was performed using NAVIOS 
(Beckman Coulter, Brea, CA, USA). 
T cell Intracellular Staining: T cells from MLNs of mice fed with tomato 
(Control or Bronze)-enriched food were cultured with a 500X Cell 
Stimulation Cocktail (eBiosceince, San Diego, CA, USA) for 12 h, washed 
with DPBS + 0.5% BSA and stained with CD4-APC-Vio700 (Miltenyi 
Biotec, Bergisch Gladbach, Germany). After washing, cells were then 
permeabilized with BD CytoFix/CytoPerm® Fixation/Permeabilization 
Kit® (BD Biosciences, Franklin Lakes, NJ, USA), washed with PERM 
Buffer, and stained with: IL-17A-FITC, TNFα-PE and IFNγ-APC 
according to manufacturer’s instructions (Miltenyi Biotec, Bergisch 
Gladbach, Germany). Flow Cytometer data analysis was performed 
using NAVIOS (Beckman Coulter). 
 
3.15 Statistical Analysis  
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All data were expressed as the means ± SEM. All results were obtained 
from three consecutive and independent experiments. Metagenomic 
data (Unifrac distance metric and taxonomic abundance) were analyzed 
by Principal Component Analysis (PCA)23 using a statistical software 
Statistica for Windows (Statistica 6.0 for Windows 1998, StatSoft, 
Vigonza, Italia). Permut-MatrixEN software was used to identify 
clusters at the level of the mouse groups and taxa.24 Statistical analysis 
of the relative abundances of microbial genera was based on Duncan’s 
Multiple Range test, with a significance level of p≤0.05. Finally, unless 
specifically described, other data and group differences were analyzed 
and compared by paired or unpaired, two-tailed Student’s t-tests.  
Cell biology data statistical significance was evaluated using two-tailed 
Student’s t test, One Way ANOVA followed by Tukey’s multiple 
comparison as post test and the 2way-ANOVA test using the Bonferroni 
as a post-test for the grouped analysis. Results were considered 






The Winnie-APCmin model 
We believed that the Winnie-APCmin could become an animal model that 
better resembles the chronic inflammatory insult recently included as a 
leading factor for cancer development (including CRC) [3]. During these 
past 3 years, we have successfully established the Winnie-APCmin colony 
and carefully characterized the development of neoplastic lesion in the 
intestine of this new model compared with all the parental lines. 
Morphological, molecular and immunological results of this study 
demonstrate that the Winnie-APCmin model is a unique model that could 
be a perfect to address the role of inflammation as a trigger for CRC in 
genetically predispose patients. In fact, the intestinal epithelium of 
Winnie- APCmin mice develops dysplastic lesions at early time points 
with a progression over time that confirm a multi-step process for CRC 
carcinogenesis.  
 
4.01: Winnie-APCMin murine line pathological features. 
To generate a mouse model that reflect the increased intestinal cancer 
risk of UC patients we used a mice breeding strategy counted on double 
heterozygote mutations (on Muc2 and APCMin genes) for males and 
single heterozygote mutation (Muc2) for females (Figure 8A). This 
strategy allowed obtaining colitis associated-CRC (CA-CRC) model 
(Winnie-APCMin) together with all the parental strains (WT, Winnie and 
APCMin mice) from the same couple. Using this strategy, it was possible 
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to collect data related to strains survival and inflammatory features 
comparing genetically different offspring obtained from the same 
breeders. If compared with the breeding strategy used to obtain Winnie 
mice, when the APCMin mutation was introduced in the breeding scheme 
there was a reduction in the survival rate (28.6% versus 0.8%, Figure 8B). 
Similarly to what previously observed for the Winnie model, 5 week-old 
Winnie-APCMin mice were characterized by reduced body weight and 
colon length when compared to WT and APCMin used as control (Figure 
Figure 8: Creation and characterization of the Winnie-APCMin murine model. (A) Breeding strategy used 
to obtain Winnie-APCMin mice and the parental lines from the same breeders. (B) Impact of APCMin 
mutation on survival rate in the breeding scheme of Winnie mice. (C) Body weight analysis of 4-week-old 
mice from different genotypes. Representative images of colons (D) and data analysis of colon length (E) 
and colon length adjusted to the body weight (F) for Winnie-APCMin mice and control lines. C-F: 7 
animals/group. *p<0.05, ***p<0.001 compared to WT mice.  
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8C-E). These data were emphasized when the colon length was related 
to the mice weight (Figure 8F). 
 
4.02: Winnie-APCMin mice develop dysplastic lesions.  
Histological analysis of 5-week old Winnie-APCMin mice demonstrated 
the presence of dysplastic aberrant crypt foci (ACFs) along the all the 
colon length with a gradually increase in incidence and multiplicity 
moving from the proximal to the distal colon tract (Figure 9A-C). As 
expected, dysplastic ACFs are absent in the age-matched parental 
strains, excepted for APCMin mice that showed a lower incidence and 
multiplicity for the neoplastic lesions as compared to the Winnie-
APCMin mice (30% Vs 78% of incidence and a multiplicity of 0.3 ± 0.15 
Vs 2.2 ± 0.62, respectively). The dysplastic ACFs were grouped according 
to the classification of neoplastic pre-invasive intraepithelial lesions of 
the colonic mucosa. No lesions showed the proliferative compartment 
located above the muscolaris mucosa at the basal level. The aberrant 
crypts were classified by two grade of dysplasia: low (mild and 
moderate) and high (severe). The most recurring dysplasia grade was 
the moderate one, with low cigar-shaped-like nuclear crowding up to 
the lumen of the crypt. Atypical mitosis was observed rarely. Dysplastic 
ACFs were carefully characterized for incidence and multiplicity based 
on the number of crypts and the grading into four groups: unicriptic 
lesions; microadenoma >1≤5 Low Grade (LG); microadenoma >5 Low 
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Grade (LG) and microadenoma >5 High Grade (HG). All of them 
showed a tubular pattern.  
 
Winnie-APCMin mice also showed a low incidence and multiplicity of 
non dysplastic ACFs specifically in the medial tract of the colon. A 
similar incidence and multiplicity for this type of lesions is observed in 
the proximal tract of age-matched APCMin mice. Moreover, Periodic 
Figure 9: Histological characterization of the Winnie-APCMin murine model. 
Hematoxylin and eosin staining on 3μm colon sections from proximal (A), medial (B) 
and distal (C) tract of 5 week-old Winnie-APCMin mice. Images were captured at 10X 
(left) and 20X magnifications (right) [De Santis et al. Submitted Feb. 2019]. 
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Acid Schiff (PAS) staining reveals an overall decrease in mucin 
expression in the distal colon of Winnie and Winnie-APCMin mice as 
compared with WT and APCMin mice (Figure 10). Specifically, mucins 














4.03: 5 week-old Winnie-APCMin mice gene expression.  
The expression profile was evaluated from 5 week-old mice after 
obtaining mice genotype. RNA from the distal colon of 5 week-old 
Winnie-APCMin mice and all the parental strains was analysed by qPCR 
comparing the expression of 89 selected genes for CRC. Compared to 
WT, the number of genes regulated at 5 week by Winnie and Winnie-
APCMin mice was higher than the ones modulated by APCMin mice (26 
Figure 10: Mucins expression in presence of dysplasia. Periodic Acid Schiff (PAS) staining to highlight 
mucin expression in the distal colon of WT (A), Winnie (B), APCMin (C) and Winnie-APCMin (D) mice [De Santis 
et al. Submitted Feb. 2019]. 
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and 28 Vs 8, respectively) (Figure 11A). Among the 27 genes resulting 
from the Winnie-APCMin Vs WT analysis, more the a half was in common 
with Winnie (10 up and 6 down) and only one gene was shared with the 
molecular pattern of APCMin mice (down). On the contrary, when 
comparing Winnie and APCMin mice to WT, they only shared two genes 
that had a contra-regulation (Figure 11A).  
 
10 genes specifically up-regulated in Winnie-APCMin Vs WT mice 
confirmed the modulation of genes known to be involved in CRC 
progression both in mice and humans (Figure 11B). We than compared 
Figure 11: Molecular characterization of 5-week-old Winnie-APCMin distal colon. (A) Venn diagram reported qPCR 
data obtained comparing Winnie-APCMin, Winnie and APCMin relative to WT mice. (B) Histogram indicates relative 
expression of 10 specifically up-regulated genes in Winnie-APCMin (white bars) versus WT mice (black bars) (C) 
Winnie-APCMin (white bars) versus WInnie mice (black bars) (D) Winnie-APCMin (white bars) versus APCMin mice 
(black bars)  (n=3 animals/group). Histograms represent the mean of 2-ΔΔCt  ± SEM. *p<0.05, **p<0.01. [De Santis 
et al. Submitted Feb. 2019]. 
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Winnie-APCMin with Winnie and APCMin mice; the number of modulated 
genes is approximately the same (Figure 11 C, D). Only 3 genes (IL-1, 
CD44 and Mmp2) were similarly upregulated in Winnie-APCMin mice 
regardless if compared with Winnie or APCMin (Figure 11).  
  
4.04: Metagenomic analysis in 4 week-old Winnie-APCMin mice.  
 Stools were collected from 4-week old mice when separated from the 
breeding cage. Metagenomic analysis was performed comparing 
bacterial relative abundance of Winnie-APCMin mice with all the parental 
strains. The phylum profile reveals that Winnie-APCMin are 
characterized by a microbiota intermediate between Winnie and APCMin 
(Figure 12 A). The only exception is represented by the increased ratio 
between the abundance of Bacteroidetes and Prevotella in Winnie-
APCMin (Figure 12 B). This observation is important as Prevotella has 

















Figure 12: The phylum profile in the stools of Winnie-APCMin. Average relative 
abundance of the different phyla in 4-week old Winnie-APCMin mice and all the 




Nutritional strategies to reduce inflammation  
In parallel with the development of the Winnie-APCMin mice we 
explored the possibility to prevent intestinal inflammation using 
nutritional derived bioactive compounds. Together with numerous 
other research group, we already reported the anti-inflammatory 
potential of numerous natural bio-active compounds as potential 
candidate for prevention and treatment of the intestinal inflammatory 
response. [21] The possibility to suppress the inflammatory response 
may also reduce the risk to develop CRC even more if used in 
combination with classical therapies. Plant polyphenols represent one of 
the largest and most ubiquitous groups of secondary metabolites that 
are an integral part of the human diet [34]. These compounds are 
characterized by the presence of one or more phenol rings and two or 
more hydroxyl groups linked directly to the aromatic rings [35] and have 
been associated with anti-oxidant, anti-microbial, anti-proliferative and 
anti-inflammatory properties [36, 37]. Despite evidence for the biological 
effects of these phytonutrients being reported, knowledge of the 
underlying molecular mechanisms activated upon polyphenols 
treatment remain poorly understood [38, 39]. 
 
4.05: Quercetin induces Slpi expression in LPS-activated BMDCs 
In 2015, we published the results of a whole-genome microarray analysis 
performed on mRNA extracted from Quercetin and Piperine 
Reconstituted Oil Bodies (ROBs-QP) treated bone marrow derived 
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dendritic cells (BMDCs) at 6 hours post LPS exposure identified a 
number of genes that were significantly modified by polyphenols 
exposure as previously described [29]. As expected, most of the 
transcripts differentially expressed by polyphenol exposure were those 
of pro-inflammatory genes, which were significantly down-regulated 
consistent with known anti-inflammatory activity of the polyphenols. 
We identified secretory leukocyte protease inhibitor (Slpi) among the 
transcripts differently up-regulated in polyphenol exposed BMDCs 
following LPS stimulation (2.7-fold, P<0.01; Figure 13). The microarray 
data was confirmed by qPCR where Slpi expression was significantly 
up-regulated in the ROBs-QP treated BMDCs reaching a 26-fold (P<0.01) 
increase at 24h post LPS activation compared to a 4-fold increase in 
vehicle treated BMDCs. Significantly, Slpi expression was increased in 
ROBs-QP treated BMDCs even before LPS activation (7-fold induction) 









Figure 13: Quercetin induces Slpi expression in LPS-activated BMDCs. A. Slpi expression from the microarray data 
of BMDCs exposed to vehicle or ROBs-QP at day 5 and 7 and treated with 1 μg/mL of LPS for 6 hours (n=4, 
**P<0.01). B. Time course mRNA expression of Slpi mRNA measured by qPCR of BMDCs exposed to vehicle (black 
bars) or ROBs-QP (white bars) at day 5 and 7 and treated with 1 μg/mL of LPS. Fold change are expressed relative 
to vehicle at time 0. mRNA was extracted at indicated time points and bars represent the mean ± SEM of 3 
independent experiments. (*P<0.05, **P<0.01) [40]. 
39 
 
Similar Slpi expression profiles were obtained using 25 µM of synthetic 
quercetin (data not shown). For this reason, we chose to study the effect 
of a single polyphenol administration and used synthetic quercetin for 
the remainder of the study.  
 
4.06: Quercetin reduces TNFα secretion by up-regulating Slpi 
As already known, BMDCs isolated from WT mice and treated with 
quercetin showed a significant reduction in secretion of TNFα upon 
activation with LPS compared to non-treated BMDCs (50% suppression, 
P<0.01). To demonstrate the crucial importance of Slpi we treated 
BMDCs from Slpi-KO mice in the same way and observed that DCs 
failed to reduce TNFα secretion (Figure 14A). To further elucidate 
whether the observed difference in TNFα secretion in quercetin treated 
BMDCs from WT and Slpi-KO mice was indeed Slpi dependent we used 
siRNA to knockdown Slpi in WT BMDCs and assessed the TNFα 
secretion profile. siRNA knockdown of Slpi in BMDCs from WT mice (at 
day 4 of culture) also demonstrated a failure to reduce TNFα secretion 
after quercetin treatment and LPS activation (Figure 14B). In contrast, 
BMDCs from WT mice that had Slpi expression knocked-down after 
quercetin treatment (at day 6 of culture) suppressed TNFα secretion after 








Figure 14: Quercetin reduces TNFα secretion by up-regulating Slpi. A. BMDCs were cultured from WT and 
Slpi-KO mice and treated with quercetin at day 5 and 7. BMDCs cultures were exposed to 1 μg/mL of LPS and 
the secretion of TNFα was determined by ELISA after 24 hours. Bars represent mean cytokine concentration 
± SEM (n=4) for BMDCs from WT or Slpi-KO mice treated with and without quercetin (black and white bars, 
respectively, ***P<0.001). B. BMDCs were transfected with siRNA for Slpi and Lipofectamine® 3000 reagent 
(mock) at day 4, before the administration of quercetin. qPCR for Slpi demonstrated a good efficiency for 
siRNA transfection (left). Bars represent a mean fold change ± SEM (n=3) between LPS stimulated BMDCs +/- 
quercetin relative to LPS unstimulated cells +/- quercetin, respectively. **P<0.01. The secretion of TNFα was 
determined 24 hours after LPS stimulation by ELISA (right). Bars represent mean cytokine concentration ± 
SEM (n=3) for DCs treated with and without quercetin (black and white bars, respectively). ***P<0.001. C. 
BMDCs were treated with quercetin on day 5 and transfected with siRNA for Slpi at day 6 followed by 
quercetin administration at day 7 and a subsequent exposure to LPS on day 8. A good reduction in Slpi 
expression was observed by qPCR analysis (left). Bars represent a mean fold change ± SEM (n=3) between 
LPS stimulated BMDCs +/- quercetin relative to LPS unstimulated cells +/- quercetin, respectively. **P<0.01. 
The secretion of TNFα was determined 24 hours after LPS stimulation by ELISA (right). Bars represent mean 
cytokine concentration ± SEM (n=3) for DCs treated with and without quercetin (black and white bars, 
respectively). *P<0.05 [40]. 
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4.07: Quercetin effects are lost enriching the culture media with iron  
Once realized that we unrevealed a pivotal molecular pathway involved 
in quercetin inflammatory-suppressor ability, we focused our attention 
to the mechanism that triggers the inflammatory suppression. Several 
polyphenols exhibit numerous properties including phylochelation; the 
ability to complex metal ions, including highly reactive iron. Dendritic 
cell inflammatory response is also associated with modulation of several 
iron metabolism related genes. Under inflammatory conditions, 
macrophages, but also monocytes and dendritic cells (DCs), retain iron 
through ferritin, an intracellular protein that can bind up to 400 atoms 
of iron. At the same time, iron export is inhibited due to the cascade of 
events that is triggered by inflammation-mediated increased levels of 
hepcidin. Hepcidin binds to the iron-export protein ferroportin and 
consequently induces its internalization and degradation. The overall 
result is a decreased level of circulating iron and increased load of 
cytoplasmic iron in macrophages [41].  
From the aforementioned microarray, we extracted data demonstrating 
that quercetin exposure induced Ferroportin 1 Fpn1 expression (data not 
shown), thus we expected reduced intracellular iron concentration of 
iron in quercetin-treated DCs.  With the intent to visualize iron 
intracellular content, DCs were plated into glass bottom cell Culture 
dishes, at day 7, 1µM of iron was additioned in the culture media, with 
quercetin (25µM) or same volume of vehicle (1µl DMSO/1ml media).  
LPS was then additioned 24 hours later and 6 hour later, cells were 
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stained with the Iron Stain Kit. Figure 15A shows strong cytoplasmic 
blue color into LPS treated cells, while quercetin presence severely 
reduced cells positivity. We quantified the blue signal intensity in 30 
different images obtained from 3 separated experiments (Figure 15B).  
We then compared Hmox1 protein expression in DCs lysate 24h after 
LPS administration.  Figure 15C shows the immunoblot of vehicle or 
quercetin exposed DCs in presence or absence of LPS.  Vehicle and 
quercetin treated DCs expressed similar level of Hmox1, while LPS 
administration significantly reduced it.  Importantly, when LPS was 
administered to quercetin-exposed DCs, Hmox1 signal was higher than 
control.  To investigate the axis between iron chelation and quercetin, 
we additioned different concentration of iron in the DCs culture media.  
Figure 15D shows the LPS induced secretion of IL-6 and IL-12p70 by 
DCs treated with quercetin or vehicle.  The left side of the figure 15D 
shows the quercetin induced reduction of LPS-induced IL-6 and IL-
12p70 secretion.  Quercetin efficiency is gradually lost in presence of 
increasing doses of iron. Indeed, administration of 2µM of iron was able 








Figure 15: Quercetin effects are lost in presence of high doses of iron in the culture media. Histological 
staining for the determination of ferrous pigment in BMDCs, fixed paraformaldehyde 1% (A). LPS treated 
dendritic cells (right panel) and quercetin-exposed dendritic celle (left panel) cultured in FeCl3 (1µM) 
enriched media. Blue signal intensity was quantified in 30 different images obtained from 3 separeted 
experiments. Scale bar is 50µm. The histogram (B) represents the mean blue signal intensity for the iron 
staining ± SEM.  C) Western blot analysis of BMDCs lysate 24h post LPS administration.  The histogram 
represents the ratio between Hmox1 and tubulin bar quantification obtained from 3 different experiments. 
Panel D shows the LPS-induced secretion of IL-6 and IL-12p70. Quercetin (white bars) or vehicle (black bars) 
DCs were treated with FeCl3 and LPS at the indicated doses, IL-6 and IL-12p70 were determined by ELISA. 




4.08: Gut Microbiota Respond to the Iron Starvation 
It has long been known that iron availability is crucial for bacterial 
growth, and iron deprivation is an efficient strategy to limit bacterial 
growth. Recently, an increased risk of bacterial infections has been 
observed following the administration of non-physiological amounts of 
iron and, in particular, an increased virulence of Escherichia, Klebsiella, 
Listeria, Neisseria, Pasteurella, Shigella, Salmonella, Vibrio, and 
Yersinia [43]. When studied using murine models of colitis, the 
increased oxidative stress was identified as the major cause of disease 
exacerbation following oral iron administration, but several other 
mechanisms may be important, including endoplasmic reticulum stress, 
a microbial community shift and immune cells activation. Furthermore, 
in vitro results obtained using the intestinal fermentation model 
described by Cinquin et al. [44] demonstrated a direct link between iron 
restricted growth condition and the growth advantage obtained by 
Enterobacteriaceae and lactobacilli [45]. Nonetheless, these in vitro 
results were in contrast with Dostal et al. who observed marginal 
changes in gut microbiota composition in rats under low luminal Fe 
concentrations [46].  
Thanks to the collaboration with Prof. Cathie Martin in Norwich (UK) 
we had the opportunity to use a new transgenic tomato line called 
Bronze, to enrich mice chow with natural polyphenols [47]. We 
investigated any impact of the different tomato-supplemented diets on 
probiotic groups, whose growth is relevant to intestinal health (Figure 
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16). We developed different custom diets supplemented with 1% 
lyophilized fruit from the different tomato lines (wild type, Indigo, 
ResTom, and Bronze) and administered them to age- and sex-matched 
C57Bl/6 mice, for 2 weeks. In particular, mice fed with diets enriched 
with Bronze and ResTom tomato fruit were characterized by a 
significant increase in the phylum Bacteroidetes and a decrease in 
Firmicutes, resulting in a significant increase (P < 0.05) in the ratio of 
Bacteroidetes to Firmicutes which doubled from 0.86 in mice fed the 
standard diet to 1.74–1.79 in mice fed diets enriched with 1% ResTom 
and 1% Bronze tomato fruit, respectively (Figure 16C). These data 
suggested that dietary stilbenoids promoted growth of Bacteroidetes 





















Figure 16: Composition of the intestinal microbiota of mice fed diets enriched with different tomato 
fruit. Sex-matched mice (n = 5) were divided into five groups, based on the diet (standard diet and diets 
enriched with 1% of wild-type, Indigo, ResTom, and Bronze lyophilized tomato fruit). After 2 weeks diet, 
fecal samples were collected for the microbiota meta-analysis. (A) Circular representation of the 
phylogenetic tree showing the major 150 genera of the intestinal microbiota. The inner bands indicate 
the genera colored by phylum. The outer circles show multibar charts indicating the relative abundances 
of genera in different diet groups. (B) Relative abundances of the phyla found in the microbiome of mice 
in different diet groups. (C) Bacteroidetes/Firmicutes ratio in the microbiome of mice fed with different 
diets. (D) Relative abundances of the genera of the microbiome showing significant differences among 
diet groups. The letters above the histograms in panels (C) and (D) indicate the significant differences 
between two different diet groups assessed by Duncan’s multiple-range test [47]. 
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4.09: Effects of nutritional intervention in Winnie mice 
We demonstrated that the administration of a nutritional regime 
enriched with 1% of Bronze tomato fruit was able to promote a change 
in the composition of the microbiota in healthy mice and partially 
suppress the host inflammatory response to reduce/delay the 
appearance of intestinal damage induced by DSS administration [47]. 
In contrast to the previous experimental setup, we built on our 
published findings and used the murine model of spontaneous UC, 
Winnie, to investigate the therapeutic rather than the preventive 
potential of the Bronze-enriched diet. Our aim was to determine the 
therapeutic potential of a dietary intervention based on the Bronze-
enriched diet in adult Winnie mice.  
We explored the effects of nutritional intervention in a model of 
spontaneous progressive ulcerative colitis. WT and Winnie mice were 
fed for 2 weeks with 1% control (Control) or bronze (Bronze) tomato-
enriched diets. Figure 16A shows the experimental setup. 
Administration of the enriched diets did not alter the weight of WT and 
Winnie mice (Figure 16B) nor their colon weight and length (Figure 16C, 
D, respectively). Morphological analysis of the explanted colon did not 
reveal differences between Control and Bronze treated mice (data not 







4.10: IL-17A Reduction in CD4+ Mesenteric Lymph Node (MLN) T 
Cells Treated with a Bronze Tomato Diet 
Following two weeks of tomato-enriched diets, we isolated and 
analyzed the intracellular cytokine production of the MLNs CD4+ T 
cells. The Bronze enriched diet resulted in a reduced percentage of 
CD25+Foxp3+ (Figure 18A) and increased percentage of TNFα+ cells 
(Figure 18B) compared to the Control diet. Both changes were not 
Figure 17. Experimental design and macroscopic characterization of the experimental groups. (A) 
Sex-matched mice were divided into four groups based on their genotype (Wild Type or Winnie) and 
their diet (enriched with Control or Bronze lyophilized tomato fruit). Mouse weight was recorded at 
the beginning of diet administration (Day 0) and at the end of the trial (2 Weeks). Fecal samples were 
collected for microbial meta-analyses at both time points (Day 0 and Week 2). Tissues were explanted 
and analyzed at the end of the treatments as indicated. Analysis of mice from different groups 
included: mouse weight (B), colon weight/mouse weight (C) and colon length/mouse weight (D). Black 
bars show the values at Day 0, striped bars show the Control- and white bars the Bronze-enriched 
diet. Statistical evaluation was performed using unpaired two-tailed Student’s t-tests [48]. 
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significantly different, but the trend was consistent independent of the 
genotype of the mice. A Bronze diet resulted in a significant reduction 
in the percentage of IL-17A CD4+ cells in WT mice and a similar trend 
in Winnie mice, while the percentage of IFNγ+CD4+ cells was 
unchanged (Figure 18C) both in WT and Winnie. Of note, the percentage 
of IFNγ+CD4− cells was reduced by the Bronze diet, particularly in 
Winnie mice (Figure 18D) [48]. 
 
 
Figure 17. Mesenteric lymph node T cell cytokine staining. (A) Representative Treg staining 
of CD4+ cells. Histograms represent the percentages of Foxp3+CD25+ cells in the MLNs of 
mice fed with Control-enriched diet (striped bars) and Bronze-enriched diet (white bars). (B) 
Representative density plot analysis of intracellular staining of MLNs from Winnie mice. (C,D) 
Intracellular staining of IFNγ and IL-17A in the CD4+ (C) and CD4− (D) MLN cells of WT and 
Winnie mice after 2 weeks of Control or Bronze-enriched diets. Statistical evaluation was 
performed using unpaired two-tailed Student’s t-tests. * P < 0.05 [48]. 
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4.11: Bronze Tomato Diet Molecular Signature 
We previously demonstrated that the administration of a Bronze 
enriched diet was able to reduce the expression of inflammatory 
cytokines (Il-6, Tnf-α, Il-1α, Il-1β, Il-12) in the colon of WT mice [29] and 
that the expression level of Slpi was a reliable marker for the oral intake 
of quercetin [40, 49]. We next analyzed the expression levels of Tnf-α, 
Ifnγ, Il-10, Slpi and Hmox1 in the colon of WT and Winnie mice. While 
both a Bronze and Control enriched diet significantly increased Il-10 
expression in WT mice (Figure 18A), only a Bronze diet induced a higher 
increase in Il-10 in Winnie mice. Tnf-α and Ifnγ colon expression was 
generally lower in mice fed with Control or Bronze diets in both the 
Winnie and WT mice (Figure 18B,C). A significant reduction in Ifnγ 
expression was observed in Winnie mice fed with a Bronze diet 
compared to Day 0, but not in Winnie mice fed with a Control diet. Slpi, 
a major checkpoint for the anti-inflammatory activity of quercetin [40, 
48], was significantly induced by both the Control and the Bronze-
enriched diets both in WT and Winnie mice (Figure 18D). Slpi induction 
was higher in Winnie compared to WT mice. Hmox1 expression was 
similar to that of Slpi, suggesting an anti-inflammatory pathway that is 









4.12: Dysbiotic Intestinal Microbiota Communities Changed 
Following Two Weeks on a Bronze Tomato Diet in Winnie Mice 
Time zero for each mouse was collected both for WT and Winnie mice. 
At day 0 for the mice fed with Control tomato-enriched diet, the 
Shannon index of the Winnie mice was higher than the WT mice (2.413 
and 2.180, respectively, P = 0.011). No statistically significant differences 
were found for the number OTUs and Chao index. To investigate the 
response of the microbiota to the host intake of different dietary regimes, 
fecal material was collected from mice following two weeks of Bronze or 
Control enriched chow. After two weeks of feeding Control tomato, the 
Figure 18. Two weeks of Bronze-enriched diet induced Slpi and Hmox1 expression in the medial colon of 
WT and Winnie mice. Histograms represent the average expression of Il-10, Tnf-α, Ifnγ, Slpi and Hmox1 
(A–E respectively) measured by real time PCR in the medial colon of WT and Winnie mice after two weeks of 
Control- (striped bars) and Bronze-enriched diet (white bars). Black bars represent the gene expression at Day 
0. All bars represent mean expression ± SEM for each treatment. Control and Bronze dependent expression 
were compared to WT Day 0 for the statistical evaluation. Student’s t-test was used to compare every 
measurement to the corresponding WT Day 0 and evaluate the significance of the data. ** P < 0.01,* P < 0.05 
(Student’s t-test). Grouped analyses were performed with the two-way ANOVA test, using Bonferroni as a 
post test ANOVA p Value: IL-10: p = 0.0348; TNFα: p = 0.0523 IFNγ: p = 0.6483 Slpi: p = 0.0058 HMOX: p 
= 0.0002 [48]. 
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WT mice increased their OTUs and their Shannon index compared to 
Day 0. Compared to the Control tomato diet, all WT and Winnie mice 
showed non-significant reductions in OTUs on the Bronze tomato diet. 
In our previous studies, the diversity and richness of the microbiota of 
mice did not show significant differences (P > 0.05) in response to 
different diets [47]. The 3 phylogeny-based β-diversity analyses did not 
show statistical separation between the composition the microbiome of 
fecal mouse samples after two weeks of Bronze or Control tomato diets. 
Samples were mainly clustered according to the genotype (WT or 
Winnie mice).  
The evaluation of the 16S revealed a significant difference (P < 0.05) 
between 20-week old WT and Winnie mice. In particular, the relative 
abundance of Bacteroidetes and Firmicutes (41.97% and 39.26% in WT 
vs. 60.62% and 23.36% in Winnie mice), as well as the ratio between them 
(1.14 vs. 2.76 respectively, P = 0.022) confirmed differences already 
known for hosts characterized by ongoing intestinal inflammation 
[50,51]. Two weeks of dietary intervention changed the microbial 
content of both WT and Winnie mice. The differences in bacterial 
abundance monitored by 16S segregation, observed at time zero, were 
later lost as fecal material from WT and Winnie mice could not be clearly 












Figure 19. Total bacteria found in feces of WT and Winnie mice. Relative abundance (%) of total 
(16S rRNA) bacteria, found at the phylum level in the fecal samples of WT and Winnie mice at Day 





During these last three yeas of PhD we aimed to create a new murine model of 
spontaneous inflammatory-induced colorectal cancer a combining the genetic 
susceptibility of the APCMin model and the chronic intestinal inflammation of the 
Winnie mice. Currently, there is a sharp distinction between CRC and colitis-
associated cancer (CAC) as clinical evaluations reveal that CRC tumors do not 
arise in the context of preceding inflammation [33]. Using murine 
models of CAC a single injection of carcinogen azoxymethane (AOM) is 
sufficient to give rise to multiple colonic tumors, when if chronic colitis 
has been induced, while it takes multiple injection of carcinogen and 
longer time for tumors to form when inflammation is absent [52, 53].  
Differently from CAC, the most commonly used model of CRC is APCMin that is 
genetically predisposed to develop intestinal cancer.  APCMin mice are often treated 
with DSS to induce colonic inflammation resulting in faster CRC development.  
Differently from the DSS induced colitis, Winnie are murine models of spontaneous, 
mild and progressive ulcerative colitis that require several months to show 
histological sign of disease. During these years, we characterized the disease 
progression in Winnie [54]. 5-week old mice show reduced body weight, watery 
diarrhea, but now rectal bleeding or prolapse. Importantly, histologically no 
distinctive sign of UC is present in the colon, but a specific molecular pathway 
characterized by upregulated inflammatory cytokine transcript is present [54].    
In light of the mild inflammatory response observed in 5-wee old Winnie, it was 
surprising to realize that the colon of age matched Winnie-APCMin mice was rich of 
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dysplastic ACFs along the all the colon length with a gradually increase 
in incidence and multiplicity moving from the proximal to the distal 
colon tract (Figure 9A-C). This feature is extremely relevant as our model 
underlines the importance of chronic inflammation in genetically predisposed 
patients, even if the inflammation is considered mild. For these patients, prevention 
may represent the only effective strategy to improve/prolong disease free periods. 
The Winnie-APCMin molecular pathway underlines the unique molecular feature 
resulting from the combination of genetic predisposition and chronic inflammation. 
This still preliminary observation has been used to submit an experimental protocol 
aiming to prevent the upregulation of some of the Winnie-APCMin specific genes 
using nutritional strategies that suppress the intestinal inflammation and/or prevent 
dysbiosis. Indeed, nutritional based strategies to suppress or mitigate intestinal 
inflammation has been one of the most important research topic of our group [21, 
29, 30, 40, 48, 49]. In particular, during the the first decade of scientific career, the 
candidate contributed to understand the importance of intestinal resident DCs for 
the intestinal homeostasis and the complex dynamic of DCs recruitment and 
polarization in the intestinal lamina propria [55-60]. For this reason we used BMDCs 
as a paradigm of cells potentially affected by polyphenol exposure.    
Dendritic cells respond to quercetin exposure producing secretory leukocyte 
protease inhibitor (SLPI). SLPI is an antimicrobial protein that is also involved in 
tissue repair and possess the ability to block NFkB nuclear translocation with the 
ultimate result to suppress inflammation [61].  Using Slpi-KO DCs we 
demonstrated that Slpi induction was a necessary step following quercetin 
administration to suppress inflammatory cytokine secretion, nonetheless the 
mechanism of action that triggers Slpi production was still not clear. 
56 
 
Using an easy dose response experiment, we demonstrated that the administration 
of inorganic iron was able to block quercetin in a dose dependent manner. As 
quercetin is a strong iron chelating agent [62, 63] we proposed that quercetin-iron 
chelation may result in DCs cytoplasmic loss of iron reservoir and consequent 
switch to an inflammatory-impaired phenotype [64, 65]. At the same time, 
nutritional intake of quercetin may contribute to sequestrate iron from the intestinal 
lumen, suppressing bacterial growth. This aspect was partially explored using 
polyphenol enriched diet administered to WT or Winnie mice. Dysbiosis is partially 
recovered after two weeks of 1% enriched diet. Currently ongoing experiments will 
demonstrate if enriched diet may be used as prevention strategies to suppress 
inflammation and prevent intestinal dysbiosis, particularly in the context of CRC 
genetically predisposed individuals.  
The Winnie-APCMin model will be crucial to evaluate the efficiency of the 
polyphenol-enriched nutritional strategies and, potentially, many different 
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